These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25443136)

  • 1. The economic burden of diabetes in India: a review of the literature.
    Yesudian CA; Grepstad M; Visintin E; Ferrario A
    Global Health; 2014 Dec; 10():80. PubMed ID: 25443136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia.
    Ganasegeran K; Hor CP; Jamil MFA; Loh HC; Noor JM; Hamid NA; Suppiah PD; Abdul Manaf MR; Ch'ng ASH; Looi I
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China.
    Wu H; Eggleston KN; Zhong J; Hu R; Wang C; Xie K; Chen Y; Chen X; Yu M
    BMJ Open; 2018 Nov; 8(11):e020647. PubMed ID: 30389755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Impact of Diabetes in Africa.
    Mapa-Tassou C; Katte JC; Mba Maadjhou C; Mbanya JC
    Curr Diab Rep; 2019 Jan; 19(2):5. PubMed ID: 30680578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
    Javanbakht M; Baradaran HR; Mashayekhi A; Haghdoost AA; Khamseh ME; Kharazmi E; Sadeghi A
    PLoS One; 2011; 6(10):e26864. PubMed ID: 22066013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of diabetes and its complications in Poland.
    Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of type 2 diabetes and its complications in India and economic costs to the nation.
    Pradeepa R; Mohan V
    Eur J Clin Nutr; 2017 Jul; 71(7):816-824. PubMed ID: 28422124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study.
    Erzse A; Stacey N; Chola L; Tugendhaft A; Freeman M; Hofman K
    Glob Health Action; 2019; 12(1):1636611. PubMed ID: 31282315
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.
    Hex N; Bartlett C; Wright D; Taylor M; Varley D
    Diabet Med; 2012 Jul; 29(7):855-62. PubMed ID: 22537247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses.
    Alzaid A; Ladrón de Guevara P; Beillat M; Lehner Martin V; Atanasov P
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):785-798. PubMed ID: 32686530
    [No Abstract]   [Full Text] [Related]  

  • 11. The Economic Costs of Type 2 Diabetes: A Global Systematic Review.
    Seuring T; Archangelidi O; Suhrcke M
    Pharmacoeconomics; 2015 Aug; 33(8):811-31. PubMed ID: 25787932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
    Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
    Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States.
    Foos V; Varol N; Curtis BH; Boye KS; Grant D; Palmer JL; McEwan P
    J Med Econ; 2015 Jun; 18(6):420-32. PubMed ID: 25629654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study.
    Afroz A; Alam K; Ali L; Karim A; Alramadan MJ; Habib SH; Magliano DJ; Billah B
    BMC Health Serv Res; 2019 Aug; 19(1):601. PubMed ID: 31455307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review.
    Gheorghe A; Griffiths U; Murphy A; Legido-Quigley H; Lamptey P; Perel P
    BMC Public Health; 2018 Aug; 18(1):975. PubMed ID: 30081871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review.
    Afroz A; Alramadan MJ; Hossain MN; Romero L; Alam K; Magliano DJ; Billah B
    BMC Health Serv Res; 2018 Dec; 18(1):972. PubMed ID: 30558591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing the burden of diabetes.
    Seaquist ER
    JAMA; 2014 Jun; 311(22):2267-8. PubMed ID: 24915253
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data.
    Wu H; Eggleston KN; Zhong J; Hu R; Wang C; Xie K; Chen Y; Chen X; Yu M
    J Diabetes Investig; 2019 Mar; 10(2):531-538. PubMed ID: 29993198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.